ArticleInternational journal of surgery (London, England)2026
The incidence and impact of early post-stroke seizures for successful endovascular stroke treatment: an individual patient data level analysis of trials.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importanceEarly post-stroke seizures (EPSS) are one of the early complications of large vessel occlusion (LVO) following endovascular treatment (EVT). However, the association between EPSS and functional outcomes remains poorly understood. Therefore, we aimed to investigate the incidence, risk factors, and clinical outcomes of EPSS in LVO patients after recanalization. MATERIALS AND
methodsThis study was an individual patient data level analysis of three randomized controlled trials conducted in China, including the RESCUE-BT, DEVT, and MARVEL trials. Acute ischemic stroke patients with LVO who underwent successful EVT within 24 h of symptom onset were enrolled. EPSS were defined as seizures occurring within 7 days of stroke onset, confirmed by clinical assessment with or without electroencephalography. The primary outcome was the poor outcome [90-day modified Rankin Scale (mRS) scores of 4-6]. Secondary outcomes included 90-day mortality, 90-day functional independence (mRS scores of 0-2), and early neurological function [defined as National Institutes of Health Stroke Scale (NIHSS) at 5-7 days or discharge].
resultsOf the 2862 patients screened for eligibility, 2524 patients achieved recanalization and were included, with a median (IQR) age of 69 (58-76) years; 1452 (57.5%) were men. A total of 71 (2.8%) patients developed EPSS. After adjustment of confounders, independent predictors of EPSS included higher baseline NIHSS scores and worse recanalization grade [the expanded thrombolysis in cerebral infarction (eTICI) 2b; P < 0.05]. EPSS were significantly associated with the poor outcome [adjusted odds ratio: 2.85, 95% confidence interval (CI): 1.66-4.88, P < 0.01] and worse early neurological function (β coefficient: 7.48, 95% CI: 4.80-10.17, P < 0.01). Propensity score matching and sensitivity analyses also showed consistent results. Mediation analysis suggested that the harmful effect of an unfavorable recanalization grade on the poor outcome was partly explained by its association with an increased risk of EPSS, which accounted for 1.8% (95% CI: 0.3%-8.6%) of the total effect.
conclusionEPSS is associated with the poor outcome in acute LVO patients who achieved successful recanalization. Complete recanalization might be associated with a lower risk of EPSS, potentially contributing to better functional outcomes. These findings provide clinically relevant insights for periprocedural management in acute LVO patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.